TITLE

A role for thrombin in liver fibrosis

AUTHOR(S)
Duplantier, J. Gillibert.; Dubuisson, L.; Senant, N.; Freyburger, G.; Laurendeau, I.; Herbert, J.-M.; Desmoulière, A.; Rosenbaum, J.
PUB. DATE
November 2004
SOURCE
Gut;Nov2004, Vol. 53 Issue 11, p1682
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background/Aim: Several lines of evidence incriminate the serine proteinase thrombin in liver fibrogenesis either through its procoagulant function or its signaling via cell-surface receptors. The aim of this study was therefore to evaluate the effect of thrombin inhibition on experimental liver fibrosis. Methods: Fibrosis was induced in rats by administration of CCl4 for either three or seven weeks. Oral administration of the thrombin antagonist SSR182289 started one week after the start of CCl4 intoxication. Fibrosis and the area occupied by alpha smooth muscle actin (ASMA) positive cells were quantified with histomorphometry. Expression of fibrosis related genes was measured by real time RT-PCR. Results: After three weeks of CCl4, treatment with SSR182289 did not significantly decrease the area of fibrosis but significantly decreased the area of ASMA positive cells by 22% (p = 0.03) and the expression of TIMP-1 mRNA by 52% (p = 0.02). There was no effect on gene expression of collagen I, MMP-2, or TIMP-2. After seven weeks of CCl4, treatment with SSR182289 resulted in a significant decrease in fibrosis (-30%, p = 0.04) and ASMA positive areas (-35%, p = 0.05). SSR182289 alone had no effect on the measured parameters. Additionally, it did not alleviate the acute toxicity of CCl4 as shown by measuring levels of serum aminotransferases and the area of necrosis. Conclusions: These data provide evidence that thrombin antagonism can reduce liver fibrogenesis. The early effect of SSR182289 on ASMA and TIMP-1 expression suggests that it is beneficial in reducing fibrogenic cell activation.
ACCESSION #
22269087

 

Related Articles

  • A role thrombin in liver fibrosis. Duplantier, J. Gillibert; Dubuisson, L.; Senant, N.; Freyburger, G.; Laurendeau, I.; Herbert, J-M.; Desmoulière, A.; Rosenbaum, J. // Gut;Dec2004, Vol. 53 Issue 12, p1682 

    Background/Aim: Several lines of evidence incriminate the serine proteinase thrombin in liver fibrogenesis either through its procoagulant function or its signaling via cell-surface receptors. The aim of this study was therefore to evaluate the effect of thrombin inhibition on experimental liver...

  • Thrombin-stimulated expression of monocyte chemoattractant protein-1 (MCP-1) involves p22phox and p38 MAP kinase phosphorylation in human smooth muscle cells.  // Pflugers Archiv European Journal of Physiology;Apr2000 Supplement, Vol. 439, pR318 

    An abstract of the article "Thrombin-stimulated expression of monocyte chemoattractant protin-1 (MCP-1) involves p22phox and p38 MAP kinase phosphorylation in human smooth muscle cells" is presented. The paper investigates whether thrombin can induce the generation of reactive oxygen species in...

  • Increased immunoreactivities against endothelin-converting enzyme-1 and monocyte chemotactic protein-1 in hepatic stellate cells of rat fibrous liver induced by thioacetamide. Nagata, Takahisa; Kudo, Hideaki; Nishino, Tomoko; Doi, Yoshiaki; Itoh, Hideaki; Fujimoto, Sunao // Medical Molecular Morphology;Sep2005, Vol. 38 Issue 3, p161 

    The progression of rat liver fibrosis induced by intraperitoneal administration of thioacetamide (TAA) was evaluated by immunocytochemistry using anti-α-smooth muscle actin (α-SMA), antiendothelin-converting enzyme (ECE)-1, and anti-monocyte chemotactic protein (MCP)-1 antibodies. The...

  • Role of the thrombin receptor in development and evidence for a second receptor. Connolly, Andrew J.; Ishihara, Hiroaki // Nature;6/6/1996, Vol. 381 Issue 6582, p516 

    Presents a study on the role of the thrombin receptor in embryology. Defining the roles of cloned thrombin receptor in vivo; Function of coagulation proteases;Discovery of a second platelet thrombin receptor; Correlation between mice embryo deaths and thrombin receptors.

  • Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model. Kim, Moon; Baik, Soon; Park, Dong; Jang, Yoon; Suk, Ki; Yea, Chang; Lee, Il; Kim, Jae; Kim, Hyun; Kwon, Sang; Cho, Mi; Ko, Sang; Chang, Sei; Um, Soon; Han, Kwang-Hyub // Journal of Gastroenterology;2008, Vol. 43 Issue 11, p889 

    Angiotensin blockade such as with an angiotensin II receptor blocker (ARB) or angiotensinconverting enzyme inhibitor (ACEI) has antifibrotic properties. The aim of this study was to evaluate and compare the antifibrotic effect between ARBs and ACEIs. Common bile duct-ligated (BDL) adult...

  • Treatment of Inadvertent Pericardial Placement of a Tunneled Dialysis Catheter by Direct Thrombin Injection. Costantino, Mary Marcelle; Barton, Robert; Slater, Matthew; McAnulty Jr., John H.; Keller, Frederick S. // CardioVascular & Interventional Radiology;Jul/Aug2006, Vol. 29 Issue 4, p675 

    An inadvertent case of pericardial placement of a central venous catheter was successfully treated by direct thrombin injection.

  • THE INFLUENCE OF STORAGE ON THE COAGULATION FACTORS OF HUMAN PLASMA. Fantl, P.; Nance, Margaret H. // Australian Journal of Experimental Biology & Medical Science;May1948, Vol. 26 Issue 3, p207 

    The factors responsible for the decline in coagulability of stored human plasma are: firstly, an increase of thrombin inhibitors, and secondly, a gradual loss of prothrombin accelerator, a process which is complete after four weeks at 20°C. A much smaller loss of prothrombin occurs during...

  • THROMBIN COMPONENTS IN BLOOD COAGULATION. Lyons, R. N. // Australian Journal of Experimental Biology & Medical Science;Sep1951, Vol. 29 Issue 5, p383 

    Two components of thrombin have been isolated and their mode of action described. Both these components appear to derive from prothrombin, and not from other accessory factors associated with coagulation.

  • We read. Ellis, Peter K.; Kennedy, Peter T.; Collins, Anton J. // CardioVascular & Interventional Radiology;Nov/Dec2005, Vol. 28 Issue 6, p854 

    Evaluates the case report of Kasthuri concerning the percutaneous ultrasound-guided thrombin injection of edoleaks. Claim of the author that the thrombin injection technique is new to them; Recurrence of type 2 endoleak.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics